Program Overview

The program is specifically designed to enhance current knowledge about the prevention, intervention and management of cardiovascular diseases.  Presentations will provide Advanced Practice Nurses, Physician Assistants and Clinical Nurses with evidence-based approaches regarding preventing readmissions of patients with acute myocardial infarction, understanding cardiac implanted devices, new hypertension guideline, cardiovascular disease prevention, Right Ventricular failure, Fractional Flow Reserve (FFR) guided therapy, acute stroke in cardiac patients, acute endocarditis, and highlights in quality improvement.


Program Overview

Provide the Advanced Practice Nurses, Physician Assistants the current knowledge in the prevention, intervention and management of cardiovascular diseases.

Learning Objectives

  • Understanding the management and usage of implantable electronic devices .
  • Review the updated 2017 AHA/ACC hypertension guideline
  • Review the importance of accurate blood pressure measurements in clinical practice ยท
  • Describe the principles of exercise programs for cardiac patients
  • Review the existing recommendations focused on the primary prevention of atherosclerotic cardiovascular diseases
  • Identify common causes, manifestations, physical exam, laboratory abnormalities, cultures, and
  • approaches to treat infective endocarditis
  • Review the clinical indicators and management of patients with right heart failure
  • Describe the quality metrics for cardiovascular disease and how we can improve quality care
  • Review heart disease and stroke prevention
  • Discuss the multidisciplinary care coordination to ensure a safe transition of patients from hospital to home
  • Describe the strategy to provide health equity and align with diversity and inclusion goal
  • Review the impact of medical errors and how to decrease the incidence of occurrence


This education activity is pending approval by the American Association of Nurse Practitioners of up to 8.75 total contact hours with 3.5 accredited pharmacology content. This program was planned in accordance with AANP CE Standards and Policies.

Faculty Disclosure

It is the policy of The Icahn School of Medicine at The Mount Sinai Hospital to ensure objectivity, balance, independence, transparency, and scientific rigor in all sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship.


Presenters must also make a meaningful disclosure to the audience about their discussion of unlabeled or unapproved drugs or devices. This information will be available as part of the course materials.